Intensity-modulated radiation therapy for anal cancer

Brian G. Czito, Joseph M. Pepek, Jeffrey J. Meyer, Sua Yoo, Christopher G. Willett

Research output: Contribution to journalReview article

8 Scopus citations

Abstract

The contemporary treatment of anal cancer is combined-modality therapy with radiation therapy, fluorouracil, and mitomycin. This therapy results in long-term disease-free survival and sphincter preservation in the majority of patients. Tempering these positive results is the high rate of treatment-related morbidity associated with chemoradiation therapy for anal cancer. The use of intensity-modulated radiation therapy (IMRT) has the potential to reduce acute and chronic treatment-related toxicity, minimize treatment breaks, and potentially improve disease-related outcomes by permitting radiation dose escalation in selected cases.

Original languageEnglish (US)
JournalONCOLOGY
Volume23
Issue number12
StatePublished - Nov 15 2009

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Intensity-modulated radiation therapy for anal cancer'. Together they form a unique fingerprint.

  • Cite this

    Czito, B. G., Pepek, J. M., Meyer, J. J., Yoo, S., & Willett, C. G. (2009). Intensity-modulated radiation therapy for anal cancer. ONCOLOGY, 23(12).